Crowdonomics
All companies
CALIBRE BIOMETRICS logo

CALIBRE BIOMETRICS

Operating

Calibre Biometrics Inc.

Healthcare · Technology · Wellesley Hills, MA · Founded 2022

Revolutionizing breath measurement through ultralight wearable device

Post-money valuation ⓘ
$22.8M
As of Mar 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$1,383,887
Crowd $59K · Private $1.3M · 2 rounds since 2021
Latest share price
$2.50
Reg CF · Common Stock · Jan 2023 offering price

Financials

FY2020–FY2021 · from SEC filings · hover any figure for its source
$0
−$475K
2020
$0
−$1.8M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$475,411
-$1,753,269
Taxes paid
$0
$0
Balance sheet
Cash
$19,054
$431,447
Accounts receivable
$0
$0
Total assets
$19,054
$439,915
Short-term debt
$91
$329,808
Long-term debt
$0
$450,000
Total liabilities
$91
$779,808
Other
Headcount
—
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$22.8M
pre-money
Reg CF · Common · Jan 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Jan 19, 2023

  • Variem LLC100.0%of company
  • Owned Variem LLC8,000,000 Class B Common99.4%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $58.9K / $1.2MInvestors 32Post-money $22.8M
Raised $1.3MInvestors 10

Team

5 people
Udi MeiravFounder
CEO and Founder

Calibre is the brainchild of Udi Meirav, a prolific inventor and seasoned startup CEO. Starting his career as a PhD Physicist from MIT - specializing in semiconductors - Udi evolved as a tech entrepreneur and executive, leading several startups that have brought complex, novel products to market. One of his recent companies developed air cleaning technology that reduces the amount of energy required for air conditioning, now installed in buildings around the world. He has dozens of patents to his name. Several years ago he became fascinated with the biometric significance of breath and the potential of wearable breath sensors, an idea that eventually evolved into the metabolic tracker called Calibre, which is his current passion. Udi and his wife Megan have 6 children and live near Boston.

David Ierardi
Chief Operating Officer

Dave brings over 30 years of product development and manufacturing scale-up experience in a multitude of industries including telecommunications, consumer electronics, military electronics, fuel cell technology and battery materials. He has a strong track record working at the highest levels of numerous organization in manufacturing and engineering leadership. With an educational background in mechanical engineering and computer integrated manufacturing, he has operated in a broad number of disciplines including electronics, materials, software and has built and led multidisciplinary teams. Dave has an unmistakeable passion for product development and large scale, high quality production.

Raviv Shefet
Chief Financial Officer

Raviv is a seasoned financial exective with 25 years’ experience in U.S. and international financial and operations management, spanning the gamut from early stage venture-capital backed startups to mature, profitable businesses and publicly traded companies. His track record as CFO includes technology companies in software and hardware, among them Charidy, 33Across, WebCollage, DVTel and Selway Partners (SCP).

Sean Coakley
Marketing and Business Development

Sean is a passionate health and technology evangelist with years of experience as a business development executive and strategic partnership leader in the health-tech market. Sean's education background is in epidemiology, biochemistry and nutritional sciences, and his early career was with marketing & reserach powerhouse Gartner. Subsequenty, Sean developed a successful track record in multiple start-ups, from open-source software technologies to the consumer wearable space. Sean is also a former athlete and a globally-known respiratory performance speaker and coach, working with olympians, professional athletic teams and many well-known high performers.

James Ciriello
Director

Senior Leader of IT and Digital Transformation • Clear and pragmatic vision of how digitization transforms enterprises and industries • Extensive experience in navigating complex organizations and partnerships to accelerate and scale innovation • Turns data and information flows into assets • Translates strategy into action for large-scale business change • Published, recognized for shaping perspective on business and technology

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 4 annual reports (FY2022–FY2025)

Missing: 2022, 2023, 2024, 2025

32 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UMar 23, 20230001665160-23-000463
    EDGAR
  • Form CJan 19, 20230001665160-23-000106
    EDGAR
  • Form D/AMar 22, 20220001897609-22-000003
    EDGAR
  • Form DDec 9, 20210001897609-21-000001
    EDGAR
Source: ManualCIK 0001897609DEShare price $2.50

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.